Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Chapman

Showing results (911-920 of 1,011) with videos related to

Pageof 102
Sort By:
JAMA|June 7, 2011
KIT as a therapeutic target in metastatic melanomaRichard D Carvajal, Cristina R Antonescu, Jedd D Wolchok, et al.
The Pharmacogenomics Journal|August 22, 2012
Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatmentJ H Karnes, C W McDonough, Y Gong, et al.
Hypertension (Dallas, Tex. : 1979)|July 7, 2016
A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics IntegrationMohamed H Shahin, Yan Gong, Caitrin W McDonough, et al.
Cancer Research|March 1, 2014
Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependenceMoriah H Nissan, Christine A Pratilas, Alexis M Jones, et al.
Journal of the American Heart Association|January 28, 2015
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugsTimo P Hiltunen, Kati M Donner, Antti-Pekka Sarin, et al.
Melanoma Research|November 25, 2020
Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)F Stephen Hodi, Paul B Chapman, Mario Sznol, et al.
Oncotarget|March 1, 2018
Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of <i>COX7A1</i> in embryonic and cancer cellsMichael D West, Ivan Labat, Hal Sternberg, et al.
Nature Genetics|August 7, 2012
The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparumDaniel E Neafsey, Kevin Galinsky, Rays H Y Jiang, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2014
Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trialsMaría V Irazabal, Laureano J Rangel, Eric J Bergstralh, et al.
Nature|July 6, 2012
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionRavid Straussman, Teppei Morikawa, Kevin Shee, et al.
Pageof 102

Showing results (911-920 of 1,011) with videos related to

Sort By:
Pageof 102
JAMA|June 7, 2011
KIT as a therapeutic target in metastatic melanomaRichard D Carvajal, Cristina R Antonescu, Jedd D Wolchok, et al.
The Pharmacogenomics Journal|August 22, 2012
Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatmentJ H Karnes, C W McDonough, Y Gong, et al.
Hypertension (Dallas, Tex. : 1979)|July 7, 2016
A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics IntegrationMohamed H Shahin, Yan Gong, Caitrin W McDonough, et al.
Cancer Research|March 1, 2014
Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependenceMoriah H Nissan, Christine A Pratilas, Alexis M Jones, et al.
Journal of the American Heart Association|January 28, 2015
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugsTimo P Hiltunen, Kati M Donner, Antti-Pekka Sarin, et al.
Melanoma Research|November 25, 2020
Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)F Stephen Hodi, Paul B Chapman, Mario Sznol, et al.
Oncotarget|March 1, 2018
Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of <i>COX7A1</i> in embryonic and cancer cellsMichael D West, Ivan Labat, Hal Sternberg, et al.
Nature Genetics|August 7, 2012
The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparumDaniel E Neafsey, Kevin Galinsky, Rays H Y Jiang, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2014
Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trialsMaría V Irazabal, Laureano J Rangel, Eric J Bergstralh, et al.
Nature|July 6, 2012
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionRavid Straussman, Teppei Morikawa, Kevin Shee, et al.
Pageof 102